| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Design Therapeutics, Inc. | Chief Operating Officer | Stock option (right to buy) | 375,000 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DSGN | Design Therapeutics, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Chief Operating Officer | 05 Jan 2026, 16:13 |
| DSGN | Design Therapeutics, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Chief Operating Officer | 06 Jan 2025, 19:00 |
| DSGN | Design Therapeutics, Inc. | 02 Jan 2024 | 1 | $0 | 4 | Chief Operating Officer | 05 Jan 2024, 16:40 |
| DSGN | Design Therapeutics, Inc. | 01 Feb 2023 | 1 | $0 | 4 | Chief Operating Officer | 03 Feb 2023, 15:41 |
| DSGN | Design Therapeutics, Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief Operating Officer | 02 Feb 2022, 18:51 |